| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,081 | 40,876 | 39,655 | 42,841 | | Cost of Revenue | 5,082 | 5,004 | 4,937 | 6,673 | | | Gross Profit |
-
| 35,872 | 34,718 | 36,168 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,582 | 22,412 | 22,103 | 18,871 | | Non Recurring | 12,981 | (1,073) | 35,056 | 4,592 | | Others | 17,665 | 38,183 | 33,916 | 23,613 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (23,650) | (56,357) | (10,908) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (22,229) | (23,650) | (56,357) | (10,908) | | Interest Expense | 1,433 | 1,611 | 2,018 | 3,508 | | Income Before Tax | (23,662) | (25,261) | (58,375) | (14,416) | | Income Tax Expense | (7,919) | (9,740) | (10,928) | (5,803) | | Minority Interest | 208 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,535) | (15,521) | (47,447) | (8,613) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,535) | (15,521) | (47,447) | (8,613) | | Preferred Stock And Other Adjustments | (208) | (290) | 498 |
-
| | | Net Income Applicable To Common Shares | ($15,743) | ($15,811) | ($46,949) | ($8,613) |
|
0.07% Nasdaq 
Income Statement
